None listed
Conditions
Interventions
None listed
Sponsors
Emami Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically diagnosed with common cold 2. Beginning of the symptoms of common cold in a minimum period of 24 hours and a maximum of 72 hours prior to baseline visit; 3. Willing to comply with all requirements of the study
Exclusion criteria
Exclusion criteria: 1. Presence of significant septum deviation, compatible with impaired nasal ventilatory function, at the investigators discretion. 2. Presence of nasal polyposis to previous rhinoscopy. 3. Required antibiotic therapy for upper airway infection treatment 4. Subjects on any other investigational products within 1 month prior to randomization 5. Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure, liver failure 6. Any medical conditions which may interfere with efficacy and or safety of the treatment with the investigational product 7. Pregnant and lactating women 8. Known hypersensitivity to any of the ingredients of Vaporizing Cold Rub 9. Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his or her participation in, and completion of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in cold symptomsTimepoint: Baseline Visit, Visit1 (24hrs), Visit 2 (48hrs), Visit 3 (Day 3), Visit 4 (Day 7) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of subjects relieved completely from symptoms of cold 2. Satisfaction of the quality of sleep 3. Requirement of rescue medications 4. Skin patch test 5. Global assessment for overall change by participants and by physician 6. Adverse events, adverse drug reactions including vitals Timepoint: Baseline Visit, Visit1 (24hrs), Visit 2 (48hrs), Visit 3 (Day 3), Visit 4 (Day 7) | — |
Countries
India
Contacts
Public ContactDr Sanjay Tamoli
Target Institute of Medical Education and Research Pvt Ltd
Outcome results
None listed